...
首页> 外文期刊>Biochemistry (Moscow). Supplement, Series A. Membrane and cell biology >Tumor-Associated Cytotoxic Lymphocytes and Macrophages as Predictive Factors in Follicular Lymphoma
【24h】

Tumor-Associated Cytotoxic Lymphocytes and Macrophages as Predictive Factors in Follicular Lymphoma

机译:肿瘤相关的细胞毒性淋巴细胞和巨噬细胞作为滤泡性淋巴瘤的预测因素。

获取原文
获取原文并翻译 | 示例
           

摘要

To evaluate the prognostic significance of tumor-associated cytotoxic lymphocytes and macro- phages, an immunohistochemical study of lymph node biopsies obtained from patients with follicular lym- phoma (FL) was carried out. The immunohistochemical survey was performed using anti-granzyme B and anti-CD68 antibodies before the patients received the anti-FL treatment. It was shown that the number of cytotoxic lymphocytes (cytotoxic T lymphocytes and NK cells) in patients with good outcome (group 1, n = 31) was significantly higher (p ≤ 0.05) than in patients with poor outcome (group 2, n = 28). The number of CD68-positive macrophages in tumors with nodular-diffuse type of growth in group 2 was significantly higher (p ≤ 0.01) than in group 1. An increased number of cytotoxic lymphocytes may point to the activation of adap- tive immunity that favors the good outcome of the disease. In contrast, an increased number of macrophages was associated with a poor outcome of FL. These data suggest that the parameters of cellular microenviron- ment can be used as prognostic criteria of the FL outcome. Further investigations are needed for the elucida- tion of the role of the cellular microenvironment in the FL development.
机译:为了评估肿瘤相关的细胞毒性淋巴细胞和巨噬细胞的预后意义,对滤泡性淋巴瘤(FL)患者的淋巴结活检进行了免疫组织化学研究。在患者接受抗FL治疗之前,使用抗粒酶B和抗CD68抗体进行了免疫组织化学检查。结果表明,结果良好的患者(第1组,n = 31)的细胞毒性淋巴细胞(细胞毒性T淋巴细胞和NK细胞)的数量(p≤0.05)显着高于结果差的患者(第2组,n = 31)。 28)。第2组具有结节性弥散型生长的肿瘤中CD68阳性巨噬细胞的数量显着高于第1组(p≤0.01)。细胞毒性淋巴细胞数量的增加可能表明适应性免疫的激活有助于疾病的好结果。相反,巨噬细胞数量增加与FL的不良预后相关。这些数据表明,细胞微环境的参数可以用作FL预后的预后标准。为了阐明细胞微环境在FL发育中的作用,还需要进一步的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号